New research suggests that administering taurine, a molecule naturally produced by human cells, could boost the effectiveness of current multiple sclerosis (MS) therapies.
Little is known about how axons in the developing visual system stabilize their connections upon reaching the correct layer, but scientists at Tokyo Institute of Technology (Tokyo Tech), led by Associate Professor Takashi Suzuki, have identified two proteins that provide layer-specific stabilization.
Salk researchers discover spinal cord neurons that inhibit distracting input to focus on task at hand.
A new study is the first to identify a mechanism that could explain an early link between sound input and cognitive function, often called the 'Mozart effect.'
Ilana Witten's research, using mice to identify a neural link between spatial learning and socialization, hints at new avenues to help people with autism and other social behavior disorders that affect their prefrontal cortex.
Researchers have found a two-way link between traumatic brain injury and intestinal changes. These interactions may contribute to increased infections in these patients, and may also worsen chronic brain damage.
A drug already used to treat certain forms of cancer appears to be an effective therapy for Huntington's disease, and offers a potential pathway to treat other neurodegenerative diseases.
People with major depressive disorder have alterations in the activity and connectivity of brain systems underlying reward and memory, according to a new study in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging. The findings provide clues as to which regions of the brain could be at the root of symptoms, such as reduced happiness and pleasure, in depression.
Whether or not you have anxiety, you've probably heard of Xanax. But what's in this popular and widely prescribed drug, and how does it work? This new video from Reactions describes how Xanax works in the anxious brain: https://youtu.be/Kq6oNcd3d-U.
Symptoms of ALS, also known as Lou Gehrig's disease, may be subtle at first but develop into more obvious muscle weakness and paralysis. Recently, a University of Missouri researcher identified a potential target for therapeutics that may help to lessen the severity and progression of ALS. Researchers suggest that this same enzyme pathway also could help in the recovery of patients who have suffered strokes and other disorders.